[Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].

Introduction: Intravitreal implantation of Ozurdex(®) (Allergan Inc., Irvine, CA, USA) is being used widely for the treatment of macular edema secondary to retinal vein occlusion and in the setting of non-infectious posterior uveitis. We describe a complication little reported in the literature until now: migration of the dexamethasone implant into the anterior chamber.

[The myopic vitreous. Why is its examination so difficult?].

The examination of a high myopic vitreous is difficult for several reasons, including optic phenomena and vitreous liquefaction. The diagnosis of a posterior vitreous detachment may be problematic and confused with the observation of a large lacuna posterior margin.